Sessa Capital’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Sessa Capital’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-46,583	Closed	-$2.07M	–	43
2022 Q4	$2.07M	Sell	46,583 -35,417	-43%	-$1.49M	0.13%	30
2022 Q3	$3.5M	Hold	82,000	–	–	0.25%	28
2022 Q2	$4.58M	Hold	82,000	–	–	0.25%	27
2022 Q1	$5.09M	Hold	82,000	–	–	0.24%	37
2021 Q4	$4.52M	Hold	82,000	–	–	0.22%	35
2021 Q3	$4.31M	Hold	82,000	–	–	0.21%	32
2021 Q2	$5.65M	Hold	82,000	–	–	0.21%	40
2021 Q1	$6.32M	Hold	82,000	–	–	0.24%	26
2020 Q4	$8.12M	Buy	+82,000	New	+$10M	0.52%	19

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Sessa Capital's LKFT Position: Q1 2023 in Review

Sessa Capital sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2023, closing a stake of 46,583 shares — an estimated $2.07M sold.

Sessa Capital first reported a position in LKFT in Q4 2020 and held it in 9 quarters. The position peaked at $8.12M in Q4 2020. 75 funds tracked by Wall St. Rank hold LKFT as of Q1 2023.

Sessa Capital reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Sessa Capital sold 46,583 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2023, an estimated $2.07M.
Sessa Capital first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q4 2020 and held it in 9 quarters.
Sessa Capital's Lakefront Biotherapeutics American Depositary Shares position peaked at $8.12M in Q4 2020.
75 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2023.

Based on Sessa Capital's 13F filing for Q1 2023, filed 15 May 2023.